Private Equity Conversations with Fexingo: PE Funds, Buyouts, and Long-Hold Investing

Private equity has been steadily consolidating industrial testing and inspection labs—the companies that certify everything from aerospace components to food safety. In this episode, Lucas and Luna dig into a single illustrative deal: the 2021 acquisition of a mid-sized materials testing firm by a large PE-backed roll-up, and how the playbook of buying up fragmented, regulated, and essential service businesses is playing out in this niche. They discuss why testing labs are attractive targets—steady cash flows, high switching costs, and long-term contracts—and the risks of consolidation, including potential conflicts of interest and reduced competition. The conversation also touches on the broader trend of private equity rolling up 'boring' but essential industries, and what it means for manufacturers, regulators, and consumers. Tune in for a sharp, specific look at a slice of the economy you've probably never thought about.

#PrivateEquity #IndustrialTesting #PEBuyouts #RollUp #MergersAndAcquisitions #Finance #Business #Investing #TestingLabs #MaterialsTesting #QualityControl #Regulation #DueDiligence #Consolidation #FexingoBusiness #BusinessPodcast #Economics #FinanceNews

Keep every episode free: buymeacoffee.com/fexingo

In this episode of Private Equity Conversations, Lucas and Luna examine the wave of private equity investment sweeping through the nursing home industry in 2026. They focus on the case of a mid-sized regional chain in Ohio that was acquired by a PE firm known for aggressive cost-cutting, and trace how that played out in staffing ratios, care quality, and ultimately a bankruptcy filing. Along the way they unpack the economics of the sector: thin operating margins, heavy reliance on Medicaid reimbursement, and the growing trend of real estate investment trusts buying the properties while operators struggle. The conversation touches on regulatory scrutiny, the Biden-era staffing mandates that took effect in 2024, and why some PE firms are now shifting to a longer-hold model that prioritizes quality. If you've ever wondered who actually owns the place that cares for your aging parents, this episode gives you a concrete look at the money behind the beds.

#PrivateEquity #NursingHomes #HealthcareInvesting #LongTermCare #Medicaid #PEBuyouts #RealEstateInvestmentTrusts #StaffingRatios #CareQuality #Ohio #Bankruptcy #Regulation #Finance #Investing #BusinessPodcast #FexingoBusiness #LucasAndLuna #Healthcare

Keep every episode free: buymeacoffee.com/fexingo

Private equity is quietly consolidating the medical billing industry, buying up the companies that process claims for hospitals and physician groups. In this episode, Lucas and Luna explain why these back-office firms are attractive targets, how the roll-up model works, and what it means for doctors, patients, and the broader healthcare system. They walk through a typical deal structure, the economics of the billing process, and the regulatory questions raised by this trend. If you've ever wondered who actually gets paid when you visit a doctor, this episode is for you.

#PrivateEquity #MedicalBilling #HealthcareFinance #Buyouts #RollUp #PEInvesting #Healthcare #Finance #Business #FexingoBusiness #BusinessPodcast #Investment #MedicalBillingCompanies #HealthcareConsolidation #PEBacked #ClaimsProcessing #HealthcareEconomics #PrivateEquityPodcast

Keep every episode free: buymeacoffee.com/fexingo

Private equity has been quietly consolidating the insurance claims adjusting industry. In this episode, Lucas and Luna dig into a specific case: the roll-up of independent adjusting firms by major PE-backed platforms. They discuss the economics — claims adjusting is a $20 billion market with fragmented ownership and strong margins — and the shift from hourly billing to per-claim fees. They also explore what this means for policyholders, from potential conflicts of interest to the use of AI in claims processing. With a focus on a recent acquisition and the broader trend, they break down why adjusters are attractive targets and whether consolidation is good for the industry. If you've ever filed an insurance claim and wondered who's actually working for you, this episode offers a clear-eyed look at the forces reshaping that relationship.

#InsuranceClaims #PrivateEquity #ClaimsAdjusting #InsuranceIndustry #PEInvesting #BusinessConsolidation #Finance #Investing #InsuranceTech #AIinInsurance #PolicyholderRights #Adjuster #ClaimsProcess #FexingoBusiness #BusinessPodcast #PEBuyouts #InsuranceMarket #RiskManagement

Keep every episode free: buymeacoffee.com/fexingo

Private equity has been quietly consolidating one of the most fragmented healthcare sectors: dentistry. In this episode, Lucas and Luna unpack the rise of dental support organizations, or DSOs, which now back roughly one in five U.S. dental practices. They trace the model from its origins in the late 1990s to the current wave of mega-deals, and they examine what happens when a PE firm buys a local dentist's office. They discuss the economics—how DSOs centralize billing, procurement, and HR while dentists retain clinical control—and the trade-offs for patients and practitioners. They also look at a specific example: the roll-up of a regional chain of orthodontic clinics, and why the valuation multiples in dental services have crept higher than almost any other healthcare services niche. With a skeptical eye, they ask whether the DSO model truly improves care or just shifts profits upstream. A must-listen for anyone who's ever wondered why their dentist now has a corporate logo on the door.

#PrivateEquity #DentalSupportOrganizations #DSO #HealthcareInvesting #Dentistry #RollUp #Buyouts #Consolidation #Orthodontics #PracticeManagement #FragmentedIndustry #ValuationMultiples #Finance #Business #FexingoBusiness #BusinessPodcast #Investing #MergersAndAcquisitions

Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna dive into the wave of private equity investment sweeping the eye care industry. They explore how PE firms are consolidating optometry and ophthalmology practices, from single-location optical shops to large multi-state vision groups. The conversation centers on a specific metric: the average revenue multiple paid for eye care practices has climbed from roughly 6 times to over 10 times EBITDA in the past five years. They discuss why PE funds find eye care so attractive—stable demand, an aging population, and a highly fragmented market of independent practices. But they also unpack the downsides: concerns about over-optimization, the push for LASIK and premium lens sales, and what patients might lose when their local eye doctor is owned by a distant fund. With vivid examples and a healthy dose of skepticism, the hosts give listeners a clear-eyed view of this quiet consolidation.

#PrivateEquity #EyeCare #Optometry #Ophthalmology #PEBuyouts #HealthcareInvesting #Consolidation #VisionCenters #Lasik #LensCrafters #WarbyParker #PErollup #FragmentedMarkets #AgingPopulation #Finance #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Private equity has quietly consolidated everything from dental clinics to self-storage. Now it's setting its sights on marinas—and the economics are surprisingly compelling. In this episode, Lucas and Luna unpack the forces driving the marina roll-up, from scarce waterfront land to a deep-pocketed boomer demographic. They walk through the fragmented mom-and-pop landscape, the premium valuations being paid for marinas near major metros, and the operational playbook PE firms apply once they dock: raising slip fees, expanding dry storage, and converting transient slips to annual leases. They also explore a darker side: concerns about access, environmental compliance, and whether local communities get squeezed out. With details on recent deals, the growth of boat ownership, and the structural appeal of a hard-to-replicate asset class, this episode offers a clear-eyed look at a niche of the economy most of us never think about—until we suddenly can't afford to park our boat.

#PrivateEquity #Marinas #BoatingIndustry #RealEstate #Finance #Business #FexingoBusiness #BusinessPodcast #Investment #Consolidation #BoomerSpending #WaterfrontProperty #PEInvesting #MarinaBusiness #Leisure #Infrastructure #Lifestyle #MarketTrends

Keep every episode free: buymeacoffee.com/fexingo

Private equity has already rolled up dental chains, funeral homes, and self-storage. Now it's quietly moving into a less glamorous corner of public infrastructure: wastewater treatment. In this milestone 150th episode, Lucas and Luna unpack the economics of buying municipal sewer systems, with a close look at the recent acquisition of a mid-sized Texas utility by a Dallas-based PE firm. They explain why water assets are so attractive — recession-proof cash flows, rate-setting power, and a federal push to privatize aging infrastructure — and what it means for ratepayers. Plus, they break down the regulatory hurdles, the 40-year concession model, and the one number that makes or break a water deal. It's a classic Fexingo deep dive: one specific case, one concrete lesson you can use. Along the way, they also share a quick thought about how the show stays ad-free and listener-funded.

#PrivateEquity #WastewaterTreatment #InfrastructureInvesting #MunicipalWater #WaterUtility #PEBuyouts #LongHoldInvesting #RatepayerImpact #TexasWater #ConcessionModel #WaterInfrastructure #PEAcquisitions #Finance #Business #FexingoBusiness #BusinessPodcast #InvestmentStrategy #PublicPrivatePartnership

Keep every episode free: buymeacoffee.com/fexingo

In this episode of Private Equity Conversations, Lucas and Luna explore the quiet wave of private equity investment in pharmacy benefit managers, or PBMs. They start with the recent trend of PE firms acquiring mid-sized PBMs, using the example of a hypothetical regional PBM that was bought by a large fund. The hosts unpack the economics: PBMs sit between drug manufacturers, insurers, and pharmacies, and their revenue comes from fees, rebates, and spread pricing. With rising drug costs and regulatory scrutiny, PE firms see an opportunity to consolidate, negotiate better rebates, and sell services to payers. But there are risks: the FTC has been investigating PBM practices, and some states are pushing for transparency. Lucas and Luna also touch on the broader theme of financial engineering in healthcare, and why PBMs are attractive for long-hold investing. They end with a reflective question about the future of drug pricing under PE ownership.

#PrivateEquity #PBMs #PharmacyBenefitManagers #HealthcareInvesting #Buyouts #DrugPricing #HealthcareConsolidation #Finance #Business #Investing #PE #Pharma #FexingoBusiness #BusinessPodcast #LucasAndLuna #LongHoldInvesting #Healthcare #RollUp

Keep every episode free: buymeacoffee.com/fexingo

Episode 148 drills into a quiet but massive trend: private equity firms have been consolidating insurance brokerages at a record pace. Lucas and Luna break down the economics behind the roll-up, why brokers are such attractive targets, and what it means for agents, policyholders, and the industry's future. With a focused look at a $13 billion mega-deal and the math that drives multiples of ten times earnings before interest, taxes, depreciation, and amortization, they walk through the playbook: buy small, tuck in, scale tech, and flip to a strategic buyer. They also touch on the tension between growth and service quality, and what a listener might notice if their local independent agent gets acquired. If you've ever wondered why your insurance renewal feels different, this episode connects the dots.

#PrivateEquity #InsuranceBrokerage #RollUp #MergersAndAcquisitions #Finance #Business #FexingoBusiness #BusinessPodcast #InsuranceIndustry #PEPlaybook #TuckInAcquisition #InsuranceAgents #EBITDAMultiples #MarketConsolidation #Investing #WealthManagement #CareersInFinance #InsuranceTech

Keep every episode free: buymeacoffee.com/fexingo